Literature DB >> 20597919

Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools.

L Ioannou1, J Massie, S Lewis, V Petrou, A Gason, S Metcalfe, M A Aitken, A Bankier, M B Delatycki.   

Abstract

A screening programme for Tay Sachs disease (TSD) carrier status was introduced in high schools in Victoria, Australia in 1997, and was expanded to screen for six other genetic conditions common in the Ashkenazi Jewish population in 2008. The aim of this study was to evaluate the current programme and compare it with an evaluation of the programme when screening was offered for TSD alone. All students from Jewish high schools in Melbourne who offered the programme in 2009 were invited to participate in the study. A purpose-designed questionnaire explored the following domains: knowledge (disease and genetics), reasons for screening, anxiety, and predicted negative feelings if found to be a carrier. Two hundred and seventy-three students were offered screening, and 272 (99.6%) completed the questionnaire. Only two students chose not to have screening. Two hundred and seventy-one students were in the penultimate year of high school (99.6%) and 222 were of Ashkenazi Jewish descent (82.5%). The main reasons for choosing screening were the desire to know carrier status and convenience. Knowledge level decreased and negative feelings increased in the current cohort compared to that when screening was offered for TSD alone. We conclude that the current programme is efficient, although increasing the number of conditions resulted in a decrease in knowledge and increase in predicted negative feelings if found to be a carrier of one of the conditions. This has implications for multi-disease screening programmes that will increase in frequency as more conditions can be screened for and costs diminish.

Entities:  

Mesh:

Year:  2010        PMID: 20597919     DOI: 10.1111/j.1399-0004.2010.01459.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  15 in total

1.  Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature.

Authors:  S Janssens; A De Paepe; P Borry
Journal:  J Community Genet       Date:  2012-12-29

2.  Knowledge, attitudes, and barriers to carrier screening for the Ashkenazi Jewish panel: a Florida experience : Education and Barriers assessment for Jewish Genetic Diseases.

Authors:  Jessica R L Warsch; Sean Warsch; Elizabeth Herman; Lauren Zakarin; Adele Schneider; Jodi Hoffman; Deborah Wasserman; Deborah Barbouth
Journal:  J Community Genet       Date:  2014-01-12

3.  Patient actions and reactions after receiving negative results from expanded carrier screening.

Authors:  S A Kraft; J L Schneider; M C Leo; T L Kauffman; J V Davis; K M Porter; C K McMullen; B S Wilfond; K A B Goddard
Journal:  Clin Genet       Date:  2018-03-13       Impact factor: 4.438

4.  Tay-Sachs disease preconception screening in Australia: self-knowledge of being an Ashkenazi Jew predicts carrier state better than does ancestral origin, although there is an increased risk for c.1421 + 1G > C mutation in individuals with South African heritage.

Authors:  Raelia Lew; Leslie Burnett; Anné Proos
Journal:  J Community Genet       Date:  2011-07-15

5.  Preconception carrier screening for multiple disorders: evaluation of a screening offer in a Dutch founder population.

Authors:  Inge B Mathijssen; Kim C A Holtkamp; Cecile P E Ottenheim; Janneke M C van Eeten-Nijman; Phillis Lakeman; Hanne Meijers-Heijboer; Merel C van Maarle; Lidewij Henneman
Journal:  Eur J Hum Genet       Date:  2018-01-10       Impact factor: 4.246

6.  High school Tay-Sachs disease carrier screening: 5 to 11-year follow-up.

Authors:  Helen Curd; Sharon Lewis; Ivan Macciocca; Margaret Sahhar; Vicki Petrou; Agnes Bankier; Sari Lieberman; Ephrat Levy-Lahad; Martin B Delatycki
Journal:  J Community Genet       Date:  2013-07-27

Review 7.  Tay-Sachs disease: current perspectives from Australia.

Authors:  Raelia M Lew; Leslie Burnett; Anné L Proos; Martin B Delatycki
Journal:  Appl Clin Genet       Date:  2015-01-21

8.  Responsible implementation of expanded carrier screening.

Authors:  Lidewij Henneman; Pascal Borry; Davit Chokoshvili; Martina C Cornel; Carla G van El; Francesca Forzano; Alison Hall; Heidi C Howard; Sandra Janssens; Hülya Kayserili; Phillis Lakeman; Anneke Lucassen; Sylvia A Metcalfe; Lovro Vidmar; Guido de Wert; Wybo J Dondorp; Borut Peterlin
Journal:  Eur J Hum Genet       Date:  2016-03-16       Impact factor: 4.246

9.  Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening?

Authors:  Kim C A Holtkamp; Merel C van Maarle; Maria J E Schouten; Wybo J Dondorp; Phillis Lakeman; Lidewij Henneman
Journal:  Eur J Hum Genet       Date:  2015-05-13       Impact factor: 4.246

10.  Factors for successful implementation of population-based expanded carrier screening: learning from existing initiatives.

Authors:  Kim C A Holtkamp; Inge B Mathijssen; Phillis Lakeman; Merel C van Maarle; Wybo J Dondorp; Lidewij Henneman; Martina C Cornel
Journal:  Eur J Public Health       Date:  2017-04-01       Impact factor: 3.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.